http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103157101-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d1e5a9014638a5450efe152d67d83ee |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b0dc791763cf9e386a5081aabf9dcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8570a579699bffbd63787bdd2eea6564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d72c0b637ac6a62e181a221f7383844 |
| publicationDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103157101-B |
| titleOfInvention | Combined inactivate vaccine for haemophilus parasuis disease and streptococcus suis disease and preparation method for same |
| abstract | The invention relates to a combined inactivate vaccine for haemophilus parasuis disease and streptococcus suis disease and a preparation method for the same. The vaccine is prepared from inactivated haemophilus parasuis serotype-4 JS strain, haemophilus parasuis serotype-5 ZJ strain, streptococcus suis serotype-2 colony-R SC strain and streptococcus suis colony-C streptococcus equisubsp zooepidemius which are used as antigens, and adjuvants which are acceptable in veterinary medicine, and capable of performing immunoprophylaxis on the haemophilus parasuis disease caused by haemophilus parasuis, the streptococcus suis disease caused by streptococcus suis, and the mixed infection of haemophilus parasuis and streptococcus suis simultaneously. The vaccine is low in side effects, free from endotoxin and impure proteins in serum, good in immune safety, capable of achieving the effect of preventing multiple diseases by one injection in clinical and thus reducing cost, and capable of meeting the requirements of different users. |
| priorityDate | 2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.